The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Much Is The Cell-based Biological Reagents Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?
The cell-based biological reagents market has demonstrated strong growth in recent years. It is projected to expand from $13.78 billion in 2025 to $14.93 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.3%. This growth observed in the past can be ascribed to the expansion of drug discovery research activities, increased spending on pharmaceutical R&D, the growing utilization of cell-based assays in toxicity testing, continuous advancements in cell culture technologies, and the rising acceptance of standardized biological reagents.
The cell-based biological reagents market is projected to experience substantial growth in the coming years. It is set to reach $20.74 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. This expansion over the forecast period is driven by factors such as a rising need for predictive in vitro models, the growth of personalized medicine research, increased utilization of AI-driven drug screening, escalating investments in regenerative medicine studies, and a heightened emphasis on complex disease modeling. Key developments anticipated during this period encompass the wider adoption of 3D cell culture and assay platforms, an increase in the use of gene-edited and reporter cell lines, a surging demand for high-throughput cell-based screening, the broadening of stem cell and primary cell applications, and a greater focus on physiologically relevant models.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33059&type=smp
What Key Drivers Are Influencing The Growth Of The Cell-based Biological Reagents Market?
The expanding emphasis on cell and gene therapies is projected to accelerate the growth of the cell-based biological reagents market. Cell and gene therapies are medical approaches that employ living cells or genetic material to mend, substitute, or alter damaged cells or genes, with the goal of treating or curing illnesses. The application of these therapies is increasing due to the rising occurrence of rare and genetic diseases, as they can target the fundamental causes at a cellular or genetic level, offering possible cures where standard treatments only manage symptoms. Cell-based biological reagents assist cell and gene therapies by providing the necessary tools and substances to effectively cultivate, modify, and deliver therapeutic cells or genetic material. For instance, in March 2024, IQVIA Holdings Inc., a US-based healthcare company focused on clinical research services and analytics, indicated that global spending on cell and gene therapies escalated to $5.9 billion in 2023, representing a 38% rise from 2022. Therefore, the heightened focus on cell and gene therapies is propelling the growth of the cell-based biological reagents market.
What Major Segment Divisions Exist Within The Cell-based Biological Reagents Market?
The cell-based biological reagents market covered in this report is segmented –
1) By Product Type: Assay Kits; Cell Lines; Reagents; Other Product Types
2) By Technology: Two Dimensional Cell Culture; Three Dimensional Cell Culture; High Throughput Screening Platforms; Stem Cell Technologies; Gene Edited Cell Platforms
3) By Application: Drug Discovery And Development; Toxicology And Safety Assessment; Disease Modeling; Regenerative Medicine; Basic Research
4) By End User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organizations; Clinical And Diagnostic Laboratories; Government And Public Health Agencies
Subsegments:
1) By Assay Kits: Cell Viability Assay Kits; Cytotoxicity Assay Kits; Proliferation Assay Kits; Apoptosis Assay Kits; Signal Transduction Assay Kits
2) By Cell Lines: Primary Cell Lines; Immortalized Cell Lines; Stem Cell Lines; Cancer Cell Lines; Transfected Cell Lines
3) By Reagents: Culture Media Reagents; Growth Factor Reagents; Enzyme Reagents; Supplement Reagents; Antibody Reagents
4) By Other Product Types: Cryopreservation Reagents; Labware Consumables; Transfection Reagents; Cell Sorting Reagents; Custom Reagents
How Are Trends Shaping The Direction Of The Cell-based Biological Reagents Market?
Leading companies in the cell-based biological reagents market are prioritizing the development of human-induced pluripotent stem cell (iPSC) research products to advance capabilities in drug discovery, disease modeling, and regenerative medicine. Human-induced pluripotent stem cell (iPSC) research products are defined as comprehensive tools and methodologies that facilitate the creation, upkeep, differentiation, and examination of iPSCs for diverse biomedical research applications, including drug screening, disease manifestation studies, and the progression of cell therapies. For example, in July 2024, BioServe Biotechnologies (India) Private Limited, an Indian biotechnology firm, unveiled an advanced range of stem cell products aimed at accelerating research in regenerative medicine and drug development. This initiative supports biotech research through dependable iPSC generation, the cultivation of 3D organoids, and precise differentiation tools, which helps to minimize experimental inconsistencies. These innovations streamline drug discovery by providing human-specific models that reduce the reliance on animal testing and quicken toxicity evaluations, thereby speeding up the development of new therapies. In the long run, they contribute to personalized medicine by enabling tissue regeneration for conditions like diabetes or heart failure, while simultaneously lowering costs and decreasing the risks of rejection.
Which Major Players Dominate The Cell-based Biological Reagents Market?
Major companies operating in the cell-based biological reagents market are Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Corp., Danaher Corporation, GE Healthcare, Becton, Dickinson And Company, Corning Incorporated, Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., STEMCELL Technologies Inc., Miltenyi Biotec, Abcam plc, Promega Corporation, Takara Bio Inc., R&D Systems Inc., MP Biomedicals, Sino Biological, Cell Signaling Technology Inc., InvivoGen, Tocris Bioscience, and OPM Biosciences.
Read the full cell-based biological reagents market report here:
https://www.thebusinessresearchcompany.com/report/cell-based-biological-reagents-market-report
Which Geographic Areas Are Emerging As Strong Markets For The Cell-based Biological Reagents Market?
North America was the largest region in the cell-based biological reagents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell-based biological reagents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Cell-based Biological Reagents Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=33059&type=smp
Browse Through More Reports Similar to the Global Cell-based Biological Reagents Market 2026, By The Business Research Company
Biotechnology Reagents Market Report 2026
https://www.thebusinessresearchcompany.com/report/biotechnology-reagents-global-market-report
Biopreservation Market Report 2026
https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report
Sequencing Reagents Market Report 2026
https://www.thebusinessresearchcompany.com/report/sequencing-reagents-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model